Cargando…

Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice

Immunotherapies use components of the immune system, such as T cells, to fight cancer cells, and are changing cancer treatment, causing durable responses in some patients. Bone metastases are a debilitating complication in advanced breast and prostate cancer patients. Approved treatments fail to cur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arellano, Danna L., Juárez, Patricia, Verdugo‐Meza, Andrea, Almeida‐Luna, Paloma S., Corral‐Avila, Juan A., Drescher, Florian, Olvera, Felipe, Jiménez, Samanta, Elzey, Bennett D., Guise, Theresa A., Fournier, Pierrick G.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543062/ https://www.ncbi.nlm.nih.gov/pubmed/35635377 http://dx.doi.org/10.1002/jbmr.4615

Ejemplares similares

TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases
por: Drescher, Florian, et al.
Publicado: (2020)

Osteocyte CIITA aggravates osteolytic bone lesions in myeloma
por: Liu, Huan, et al.
Publicado: (2022)

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
por: Gai, Dongzheng, et al.
Publicado: (2022)

MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation
por: Kagiya, Tadayoshi
Publicado: (2015)

In vitro osteolytic activity of human myeloma plasma cells and the clinical evaluation of myeloma osteoclastic bone lesions.
por: Rossi, J. F., et al.
Publicado: (1984)

Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer
por: Liu, Jin, et al.
Publicado: (2017)

Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy
por: Sengar, Prakhar, et al.
Publicado: (2018)

Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis
por: Juárez, Patricia, et al.
Publicado: (2017)

Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases
por: Ersek, Adel, et al.
Publicado: (2012)

Ra223 in Bone Metastases with Osteolytic Activity
por: Costa, Renato Patrizio, et al.
Publicado: (2018)

Arachnoid Granulations Mimicking Multiple Osteolytic Bone Lesions in the Occipital Bone
por: Park, Seong-Hyun, et al.
Publicado: (2018)

Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis
por: Coniglio, Salvatore J.
Publicado: (2018)

Bisphosphonate Treatment of Benign Multifocal and Unifocal Osteolytic Tumours of Bone
por: Gibbons, C. L. M. H., et al.
Publicado: (2003)

Melatonin Inhibits Osteoclastogenesis and Osteolytic Bone Metastasis: Implications for Osteoporosis
por: MacDonald, Iona J., et al.
Publicado: (2021)

Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease
por: Nagata, Yuki, et al.
Publicado: (2020)

Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma
por: Hensel, Janine, et al.
Publicado: (2018)

Premature Senescence of T-cells Favors Bone Loss During Osteolytic Diseases. A New Concern in the Osteoimmunology Arena
por: González-Osuna, Luis, et al.
Publicado: (2021)

Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
por: Dunn, Lauren K., et al.
Publicado: (2009)

The Hedgehog Pathway Conditions the Bone Microenvironment for Osteolytic Metastasis of Breast Cancer
por: Das, Shamik, et al.
Publicado: (2012)

Osteolytic Bone Lesions – A Rare Presentation of AML M6
por: Geetha, N., et al.
Publicado: (2015)

Osteolytic bone lesions in patients with primary myelofibrosis: A systematic review
por: Battikh, Naim Ghazi, et al.
Publicado: (2021)

An Experimental Study for Minimum Level of Decalcification to Detect the Osteolytic Bone Metastasis of Long Bone on Plain Radiography
por: Baek, Jun Ho, et al.
Publicado: (2016)

Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model
por: Regan, Jenna N., et al.
Publicado: (2017)

Bone Is Not Essential for Osteoclast Activation
por: Fuller, Karen, et al.
Publicado: (2010)

Fine needle aspiration diagnosis of Rosai-Dorfman disease in an osteolytic lesion of bone
por: Li, Shaoying, et al.
Publicado: (2010)

Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function
por: Choi, Bongkun, et al.
Publicado: (2014)

Osteolytic bone metastasis is hampered by impinging on the interplay among autophagy, anoikis and ossification
por: Maroni, P, et al.
Publicado: (2014)

Prostate carcinoma, presenting with a solitary osteolytic bone lesion to the right hip
por: Agheli, Aref, et al.
Publicado: (2015)

Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone Metastases
por: McCarty, Mark F., et al.
Publicado: (2016)

Multiple osteolytic primary peripheral T-cell bone lymphoma: the first case report
por: Li, Chen, et al.
Publicado: (2021)

The Usefulness of Bone Biomarkers for Monitoring Treatment Disease: A Comparative Study in Osteolytic and Osteosclerotic Bone Metastasis Models
por: Martín-Fernández, Marta, et al.
Publicado: (2017)

Radiation therapy combined with bone-modifying agents ameliorates local control of osteolytic bone metastases in breast cancer
por: Tanaka, Hidekazu, et al.
Publicado: (2020)

Effects of palliative radiotherapy and bisphosphonate usage on bone turnover marker levels in cancer patients with osteolytic bone metastases
por: Göksel, Fatih, et al.
Publicado: (2021)

Templated Three-Dimensional Engineered Bone Matrix as a Model for Breast Cancer Osteolytic Bone Metastasis Process
por: Sun, Manman, et al.
Publicado: (2021)

Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone
por: Aldridge, S E, et al.
Publicado: (2005)

The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis
por: Secondini, Chiara, et al.
Publicado: (2011)

Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease
por: Sawant, Anandi, et al.
Publicado: (2013)

Cancer of the prostate presenting with diffuse osteolytic metastatic bone lesions: a case report
por: Segamwenge, Innocent Lule, et al.
Publicado: (2012)

SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
por: Heusschen, Roy, et al.
Publicado: (2016)

HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice
por: Esser, Alison K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_979c8ceqoeo326drf2vtrrei1h